Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
2-[[(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]amino]succinic Acid is a derivative of the parent compound Sitagliptin Phosphate (S491000), which is a trizolopyrazine dipeptidyl peptidase IV inhibitor and it has recently been approved for the therapy of type II diabetes.